A detailed history of Curio Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Curio Wealth, LLC holds 307 shares of ABBV stock, worth $71,838. This represents 0.03% of its overall portfolio holdings.

Number of Shares
307
Previous 317 3.15%
Holding current value
$71,838
Previous $58.8 Million 20.8%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$184.85 - $231.54 $1,848 - $2,315
-10 Reduced 3.15%
307 $71.1 Million
Q2 2025

Jul 31, 2025

BUY
$170.16 - $206.27 $53,430 - $64,768
314 Added 10466.67%
317 $58.8 Million
Q1 2025

May 09, 2025

SELL
$169.2 - $216.66 $55,666 - $71,281
-329 Reduced 99.1%
3 $60.8 Million
Q4 2024

Feb 10, 2025

BUY
$164.99 - $203.87 $54,776 - $67,684
332 New
332 $59 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Curio Wealth, LLC Portfolio

Follow Curio Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Curio Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Curio Wealth, LLC with notifications on news.